Janssen Will Appeal $1.6 Billion Award in Drug Fraud Lawsuit

Janssen Products LP is appealing a federal district court’s decision that the company must pay $1.6 billion in a False Claims Act suit for improperly billing the US government for HIV drugs.

Janssen filed notice April 25 with the US District Court for the District of New Jersey that it is appealing the decision to US Court of Appeals for the Third Circuit.

• Whistleblowers Jessica Penelow and Christone Brancaccio produced sufficient evidence for a jury to conclude that the company’s off-label drug marketing was a “substantial factor in causing physicians to submit claims for reimbursement to government payors, and that ...